Wilkes NSG 533 Advanced Pharmacology
Exam 1 Prep 2026/2027 | Complete Practice
Questions & Answers Study Guide | Pass
with Confidence Review
• This 200-question practice exam covers all core Advanced Pharmacology topics
tested in NSG 533, designed to simulate real exam conditions and reinforce
mastery of drug mechanisms, clinical applications, and prescribing principles.
• Use this guide by attempting each question independently before checking the
correct answer and EXPERT RATIONALE — repeated review of missed questions
will maximize retention and exam readiness.
1. Which of the following best describes the pharmacokinetic process of first-
pass metabolism?
A. Drug absorption through the skin before reaching systemic circulation
B. Drug distribution to peripheral tissues after oral administration
C. Metabolism of a drug by the liver before it reaches systemic circulation
D. Renal excretion of a drug following hepatic conjugation
E. Drug binding to plasma proteins in the bloodstream
Correct Answer: C. Metabolism of a drug by the liver before it reaches
systemic circulation
EXPERT RATIONALE: First-pass metabolism refers to the process by which an orally
administered drug is absorbed from the GI tract and passes through the portal
circulation to the liver, where it undergoes significant metabolism before reaching
systemic circulation. This reduces the drug's bioavailability.
2. A nurse practitioner is prescribing a drug with a narrow therapeutic index.
Which pharmacokinetic parameter is most critical to monitor?
A. Onset of action
B. Volume of distribution
,C. Half-life and steady-state concentration
D. Protein-binding capacity
E. Route of administration
Correct Answer: C. Half-life and steady-state concentration
EXPERT RATIONALE: Drugs with a narrow therapeutic index have a small margin
between therapeutic and toxic concentrations. Monitoring half-life helps predict
steady-state levels and guides dosing intervals to prevent toxicity while maintaining
efficacy.
3. Which cytochrome P450 enzyme is responsible for metabolizing the largest
number of clinically used drugs?
A. CYP1A2
B. CYP2C9
C. CYP2D6
D. CYP3A4
E. CYP2E1
Correct Answer: D. CYP3A4
EXPERT RATIONALE: CYP3A4 is the most abundant hepatic cytochrome P450
enzyme and is responsible for the metabolism of approximately 50% of all clinically
used drugs. It is a major site of drug-drug interactions.
4. A patient taking warfarin is started on rifampin. What pharmacokinetic
interaction is expected?
A. Rifampin inhibits CYP2C9, increasing warfarin levels
B. Rifampin induces CYP3A4, decreasing warfarin levels
C. Rifampin inhibits P-glycoprotein, increasing warfarin absorption
,D. Rifampin displaces warfarin from protein-binding sites
E. Rifampin decreases renal clearance of warfarin
Correct Answer: B. Rifampin induces CYP3A4, decreasing warfarin levels
EXPERT RATIONALE: Rifampin is a potent inducer of multiple CYP450 enzymes
including CYP3A4 and CYP2C9. Induction increases warfarin metabolism, reducing
its plasma levels and anticoagulant effect, placing the patient at risk for
thromboembolic events.
5. Which of the following best defines bioavailability?
A. The rate at which a drug reaches its receptor site
B. The fraction of an administered dose that reaches systemic circulation
unchanged
C. The total volume in which a drug is distributed in the body
D. The time required for drug concentration to decrease by half
E. The maximum concentration a drug achieves in the plasma
Correct Answer: B. The fraction of an administered dose that reaches
systemic circulation unchanged
EXPERT RATIONALE: Bioavailability refers to the proportion of a drug dose that
reaches systemic circulation in an active form. Intravenous administration provides
100% bioavailability, while oral drugs may have reduced bioavailability due to first-
pass metabolism and incomplete absorption.
6. A drug with a high volume of distribution (Vd) is most likely:
A. Confined to the plasma compartment
B. Highly protein-bound in the bloodstream
C. Widely distributed into tissues
, D. Rapidly eliminated by the kidneys
E. Poorly absorbed from the GI tract
Correct Answer: C. Widely distributed into tissues
EXPERT RATIONALE: A high volume of distribution indicates that a large proportion
of the drug is distributed into tissues rather than remaining in the plasma.
Lipophilic drugs typically have high Vd values as they penetrate cell membranes
and accumulate in fat and other tissues.
7. Which receptor type is directly linked to an ion channel and produces the
fastest response?
A. G protein-coupled receptor
B. Tyrosine kinase receptor
C. Intracellular nuclear receptor
D. Ligand-gated ion channel
E. Enzyme-linked receptor
Correct Answer: D. Ligand-gated ion channel
EXPERT RATIONALE: Ligand-gated ion channels (ionotropic receptors) produce the
fastest pharmacological responses because binding of the ligand directly opens the
ion channel, allowing rapid ion flux within milliseconds. This is seen with nicotinic
acetylcholine receptors and GABA-A receptors.
8. What term describes a drug that binds to a receptor and produces a
submaximal response compared to a full agonist?
A. Antagonist
B. Inverse agonist
C. Partial agonist
Exam 1 Prep 2026/2027 | Complete Practice
Questions & Answers Study Guide | Pass
with Confidence Review
• This 200-question practice exam covers all core Advanced Pharmacology topics
tested in NSG 533, designed to simulate real exam conditions and reinforce
mastery of drug mechanisms, clinical applications, and prescribing principles.
• Use this guide by attempting each question independently before checking the
correct answer and EXPERT RATIONALE — repeated review of missed questions
will maximize retention and exam readiness.
1. Which of the following best describes the pharmacokinetic process of first-
pass metabolism?
A. Drug absorption through the skin before reaching systemic circulation
B. Drug distribution to peripheral tissues after oral administration
C. Metabolism of a drug by the liver before it reaches systemic circulation
D. Renal excretion of a drug following hepatic conjugation
E. Drug binding to plasma proteins in the bloodstream
Correct Answer: C. Metabolism of a drug by the liver before it reaches
systemic circulation
EXPERT RATIONALE: First-pass metabolism refers to the process by which an orally
administered drug is absorbed from the GI tract and passes through the portal
circulation to the liver, where it undergoes significant metabolism before reaching
systemic circulation. This reduces the drug's bioavailability.
2. A nurse practitioner is prescribing a drug with a narrow therapeutic index.
Which pharmacokinetic parameter is most critical to monitor?
A. Onset of action
B. Volume of distribution
,C. Half-life and steady-state concentration
D. Protein-binding capacity
E. Route of administration
Correct Answer: C. Half-life and steady-state concentration
EXPERT RATIONALE: Drugs with a narrow therapeutic index have a small margin
between therapeutic and toxic concentrations. Monitoring half-life helps predict
steady-state levels and guides dosing intervals to prevent toxicity while maintaining
efficacy.
3. Which cytochrome P450 enzyme is responsible for metabolizing the largest
number of clinically used drugs?
A. CYP1A2
B. CYP2C9
C. CYP2D6
D. CYP3A4
E. CYP2E1
Correct Answer: D. CYP3A4
EXPERT RATIONALE: CYP3A4 is the most abundant hepatic cytochrome P450
enzyme and is responsible for the metabolism of approximately 50% of all clinically
used drugs. It is a major site of drug-drug interactions.
4. A patient taking warfarin is started on rifampin. What pharmacokinetic
interaction is expected?
A. Rifampin inhibits CYP2C9, increasing warfarin levels
B. Rifampin induces CYP3A4, decreasing warfarin levels
C. Rifampin inhibits P-glycoprotein, increasing warfarin absorption
,D. Rifampin displaces warfarin from protein-binding sites
E. Rifampin decreases renal clearance of warfarin
Correct Answer: B. Rifampin induces CYP3A4, decreasing warfarin levels
EXPERT RATIONALE: Rifampin is a potent inducer of multiple CYP450 enzymes
including CYP3A4 and CYP2C9. Induction increases warfarin metabolism, reducing
its plasma levels and anticoagulant effect, placing the patient at risk for
thromboembolic events.
5. Which of the following best defines bioavailability?
A. The rate at which a drug reaches its receptor site
B. The fraction of an administered dose that reaches systemic circulation
unchanged
C. The total volume in which a drug is distributed in the body
D. The time required for drug concentration to decrease by half
E. The maximum concentration a drug achieves in the plasma
Correct Answer: B. The fraction of an administered dose that reaches
systemic circulation unchanged
EXPERT RATIONALE: Bioavailability refers to the proportion of a drug dose that
reaches systemic circulation in an active form. Intravenous administration provides
100% bioavailability, while oral drugs may have reduced bioavailability due to first-
pass metabolism and incomplete absorption.
6. A drug with a high volume of distribution (Vd) is most likely:
A. Confined to the plasma compartment
B. Highly protein-bound in the bloodstream
C. Widely distributed into tissues
, D. Rapidly eliminated by the kidneys
E. Poorly absorbed from the GI tract
Correct Answer: C. Widely distributed into tissues
EXPERT RATIONALE: A high volume of distribution indicates that a large proportion
of the drug is distributed into tissues rather than remaining in the plasma.
Lipophilic drugs typically have high Vd values as they penetrate cell membranes
and accumulate in fat and other tissues.
7. Which receptor type is directly linked to an ion channel and produces the
fastest response?
A. G protein-coupled receptor
B. Tyrosine kinase receptor
C. Intracellular nuclear receptor
D. Ligand-gated ion channel
E. Enzyme-linked receptor
Correct Answer: D. Ligand-gated ion channel
EXPERT RATIONALE: Ligand-gated ion channels (ionotropic receptors) produce the
fastest pharmacological responses because binding of the ligand directly opens the
ion channel, allowing rapid ion flux within milliseconds. This is seen with nicotinic
acetylcholine receptors and GABA-A receptors.
8. What term describes a drug that binds to a receptor and produces a
submaximal response compared to a full agonist?
A. Antagonist
B. Inverse agonist
C. Partial agonist
